한글목차

세계의 정형외과용 임플란트 시장 규모는 2024년 209억 4,000만 달러에서 2029년에는 264억 7,000만 달러에 달할 것으로 예측되며, 2024-2029년 CAGR은 4.8%에 달할 것으로 보이고 있습니다. 다양한 유형의 정형외과용 임플란트에 대한 접근성이 증가하고 제조 공정에서 3D 프린팅을 사용하는 등 기술 발전으로 인해 정형외과용 임플란트에 대한 수요가 증가하고 있습니다. 또한 골절 및 관절 손상을 유발할 수 있는 사고 및 스포츠 부상의 발생률 증가는 정형외과용 임플란트에 대한 수요를 증가시키고 있습니다.

정형외과 임플란트 시장은 유형별로 슬관절 임플란트, 고관절 임플란트, 어깨 임플란트, 팔꿈치 임플란트, 발 및 발목 임플란트, 손목 임플란트, 기타 임플란트 등으로 분류되며, 2023년에는 슬관절 임플란트가 가장 높은 점유율을 차지할 것으로 예상됩니다. 기술 혁신 증가, 비만 환자 증가, 무릎 관절 치환술에 대한 유리한 상환 시나리오가 이 부문의 성장을 가속할 것으로 예상됩니다. 환자의 예후를 개선하는 로봇 보조 슬관절 치환술의 개발도 이 부문의 성장을 가속하는 요인 중 하나입니다. 예를 들어 스트라이커(Stryker)의 마코(Mako) 무릎 인공관절 치환술은 기존 수술에 비해 불편함이 적고 회복 기간이 짧습니다.

정형외과용 임플란트 시장은 재료에 따라 금속 및 금속 합금, 세라믹, 폴리머, 하이브리드 임플란트 등으로 세분화할 수 있습니다. 역견관절 치환술과 같은 인공관절 치환술 증가와 긴 수명 및 내식성과 같은 고유한 특성이 이 부문의 성장을 주도하고 있습니다. 금속 합금은 다른 재료에 비해 저렴하고 쉽게 구할 수 있습니다. 이는 특히 가격에 민감한 시장에서 환자 및 기타 의료 전문가에게 적합한 선택이 되어 이 부문의 성장을 가속할 것으로 예상됩니다.

정형외과 임플란트 시장은 최종사용자별로 병원 및 수술센터와 외래 및 외상 치료 센터로 구분됩니다. 외래 및 외상 치료 센터는 예측 기간 중 큰 성장을 기록할 것으로 예상되며, Definitive Healthcare에 따르면 2018-2022년 기간 중 외래수술센터(ASC)에서 수행되는 무릎 관절 치환술은 304% 증가할 것으로 예상됩니다. 비용 효율성과 접근성이 이 부문의 성장을 가속할 것으로 예상됩니다. 또한 최소 침습 수술 기술로 인한 회복 시간 단축은 이 부문의 성장을 지원할 것으로 예상됩니다.

세계의 정형외과용 임플란트 시장에 대해 조사했으며, 제품별, 재료별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 밸류체인 분석
• 공급망 분석
• 에코시스템 분석
• 규제 상황
• 상환 시나리오
• 투자와 자금조달 시나리오
• 가격 분석
• 무역 분석
• 특허 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 2024-2025년의 주요 컨퍼런스와 이벤트
• 사례 연구 분석
• 기술 분석
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 미충족 요구
• AI/생성형 AI가 정형외과용 임플란트 시장에 미치는 영향

제6장 정형외과용 임플란트 시장(유형별)

• 서론
• 슬관절 임플란트
• 고관절 임플란트
• 어깨 임플란트
• 팔꿈치 임플란트
• 발과 발목 임플란트
• 손목 임플란트
• 기타

제7장 정형외과용 임플란트 시장(재료별)

• 서론
• 하이브리드 임플란트
• 금속 및 금속 합금
• 폴리머
• 세라믹

제8장 정형외과용 임플란트 시장(최종사용자별)

• 서론
• 병원과 외과 센터
• 외래·외상 케어 센터

제9장 정형외과용 임플란트 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 고품질 치료의 제공 확대가 시장을 촉진
  • 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/강점, 2021-2024년
• 매출 분석, 2019-2023년
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제11장 기업 개요

• 주요 참여 기업
  • ZIMMER BIOMET HOLDINGS, INC.
  • STRYKER CORPORATION
  • JOHNSON & JOHNSON MEDTECH
  • SMITH+NEPHEW
  • B. BRAUN
  • GLOBUS MEDICAL, INC.
  • ARTHREX, INC.
  • ENOVIS
  • ACUMED LLC
  • ORTHOFIX MEDICAL INC.
  • MICROPORT SCIENTIFIC CORPORATION
  • CONMED CORPORATION
  • MEDACTA INTERNATIONAL
  • PARAGON 28, INC.
  • MERIL LIFE SCIENCES PVT. LTD.
• 기타 기업
  • FH ORTHO SAS
  • SYMBIOS ORTHOPEDIE S.A.
  • MADISON ORTHO
  • GREEN SURGICALS PVT. LTD.
  • SIORA SURGICALS PRIVATE LIMITED
  • ORTHOPEDIATRICS CORP.
  • RESTOR3D
  • DOUBLE MEDICAL TECHNOLOGY INC.
  • TREACE MEDICAL CONCEPTS, INC.
  • AK MEDICAL HOLDINGS LIMITED

제12장 부록

영문목차

The global orthopedic implants market is expected to reach 26.47 billion by 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Increased access to various type of orthopedic implants and technological advancements such as use of 3D printing with the manufacturing process has increased demand for the orthopedic implants. Further, increased incidence of accidents and sport injuries that may result in fractures and damage to the joints has enhanced the demand for the orthopedic implants.

"The knee implants segment of type segment held the largest share of the market in 2023"

The orthopedic implants market is segmented based on type into knee implants, hip implants, shoulder implants, elbow implants, foot & ankle implants, wrist implants and other implants. The knee implants accounted for a the highest share in 2023. Increase in technological innovations, rise in number of obesity cases and the favorable reimbursement scenario for knee replacement procedures is anticipated to fuel the growth of the segment. Developments in robotic assisted knee replacement procedures that improves patient outcomes is another factor propelling the segment expansion. For example, compared to traditional surgery, the Mako Total Knee Replacement from Stryker Corporation can result in less discomfort and a shorter recovery period.

"The metals and metal alloys segment of material segment held the largest share of the market in 2023"

The orthopedic implants market can be segmented based on material into metals and metal alloys, ceramics, polymers and hybrid implants. Growing number for joint replacement surgeries such as reverse shoulder arthroplasty and unique properties such as longevity and resistance to corrosion drive the segment growth. Metal alloys are less expensive and more readily available than other materials. This makes them an appropriate choice for patients and other healthcare professionals especially in areas of price-sensitive markets, and is expected to fuel the segment growth.

"The ambulatory and trauma care centers segment for the end user segment is projected to register a significant CAGR during the forecast period."

The orthopedic implants market is segmented by end-users into hospitals & surgical centers and ambulatory & trauma care centers. The ambulatory and trauma care centers is projected to register significant growthduring the forecast period. According to Definitive Healthcare there is 304% increase in knee replacement procedures performed in ambulatory surgery centers during the period of 2018-2022. The cost-effectiveness and accessibility anticipated to propel the segment growth. Furthermore, reduced recovery time using minimally invasive surgical techniques is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in orthopedic implants market. Healthcare infrastructure and service investments, in the emerging economies, are fostering the demand for orthopedic implants. Furthermore, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for orthopedic surgeries and joint replacements. According to International Osteoporosis Foundation more than 50% of osteoporotic hip fractures are expected to occur by 2050.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: Director-level-10%, C-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and Middle East & Africa - 2%

The prominent players in the orthopedic implants market are as Stryker Corporation (US), Zimmer Biomet Holdings,Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Globus Medical, Inc. (US), Arthrex, Inc.(US), Enovis (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India)

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market stratergies

Research Coverage

This report studies the orthopedic implants market based on type, material, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall orthopedic implants market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing demand for minimally invasive orthopedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopedic diseases and disorders, and increasing research funding and awareness initiatives), restraints (risk and complications associated with orthopedic surgical procedures, high costs of orthopedic surgery), opportunities (growth opportunities in merging markets, advancements in robotic surgery and 3D printing), and challenges (dearth of skilled orthopedic surgeons) influencing the growth of the orthopedic implants market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the orthopedic implants market
• Market Development: Comprehensive information about lucrative markets-the report analyses the orthopedic implants market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the orthopedic implants market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Growth forecast approach
    • 2.2.1.4 CAGR projections
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ORTHOPEDIC IMPLANTS MARKET OVERVIEW
• 4.2 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE
• 4.3 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL
• 4.4 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY END USER (USD MILLION)
• 4.5 GEOGRAPHIC GROWTH OPPORTUNITIES IN ORTHOPEDIC IMPLANTS MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of orthopedic diseases and disorders
    • 5.2.1.2 Increasing demand for minimally invasive surgery
    • 5.2.1.3 Rising number of sports injuries
    • 5.2.1.4 Increasing research funding and awareness initiatives
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risks and complications associated with orthopedic surgical procedures
    • 5.2.2.2 High cost of orthopedic surgery
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Advancements in robotic surgery and 3D printing
    • 5.2.3.2 Growth opportunities in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Dearth of skilled orthopedic surgeons
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 MANUFACTURERS
    • 5.4.1.1 Prominent companies
    • 5.4.1.2 Small and medium-sized enterprises
  • 5.4.2 END USERS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6.2 REGULATORY ANALYSIS
    • 5.6.2.1 North America
      • 5.6.2.1.1 US
      • 5.6.2.1.2 Canada
    • 5.6.2.2 Europe
    • 5.6.2.3 Asia Pacific
      • 5.6.2.3.1 Japan
      • 5.6.2.3.2 China
      • 5.6.2.3.3 India
    • 5.6.2.4 Latin America
      • 5.6.2.4.1 Brazil
  • 5.6.3 REGULATORY APPROVALS
• 5.7 REIMBURSEMENT SCENARIO
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE, BY REGION
  • 5.9.2 AVERAGE SELLING PRICE, BY KEY PLAYER
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 9021
  • 5.10.2 EXPORT DATA FOR HS CODE 9021
• 5.11 PATENT ANALYSIS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 KEY BUYING CRITERIA
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS
  • 5.15.2 PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM
  • 5.15.3 ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D
• 5.16 TECHNOLOGY ANALYSIS
  • 5.16.1 KEY TECHNOLOGIES
    • 5.16.1.1 3D printing/additive manufacturing
  • 5.16.2 COMPLEMENTARY TECHNOLOGIES
    • 5.16.2.1 Robotic orthopedic surgery
  • 5.16.3 ADJACENT TECHNOLOGIES
    • 5.16.3.1 Diagnostic imaging
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.18 UNMET NEEDS
• 5.19 IMPACT OF AI/GEN AI ON ORTHOPEDIC IMPLANTS MARKET
  • 5.19.1 KEY USE CASES

6 ORTHOPEDIC IMPLANTS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 KNEE IMPLANTS
  • 6.2.1 ONGOING INNOVATION IN KNEE IMPLANTS TO SUPPORT GROWTH
• 6.3 HIP IMPLANTS
  • 6.3.1 RISING NUMBER OF HIP FRACTURES AND INCREASING SUCCESS RATE OF HIP ARTHROPLASTY TO SUPPORT MARKET GROWTH
• 6.4 SHOULDER IMPLANTS
  • 6.4.1 LAUNCH OF NEW SHOULDER REPLACEMENT IMPLANTS AND RISING POPULARITY OF REVERSE SHOULDER ARTHROPLASTY TO SUPPORT MARKET GROWTH
• 6.5 ELBOW IMPLANTS
  • 6.5.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET
• 6.6 FOOT & ANKLE IMPLANTS
  • 6.6.1 RISING NUMBER OF ANKLE REPLACEMENT PROCEDURES TO FUEL MARKET GROWTH
• 6.7 WRIST IMPLANTS
  • 6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET
• 6.8 OTHER IMPLANTS

7 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL

• 7.1 INTRODUCTION
• 7.2 HYBRID IMPLANTS
  • 7.2.1 IMPROVED BIOCOMPATIBILITY, BETTER MECHANICAL PERFORMANCE, AND REDUCED RISKS OF REVISION SURGERIES TO DRIVE MARKET
• 7.3 METALS & METAL ALLOYS
  • 7.3.1 STAINLESS STEEL
    • 7.3.1.1 Growing affordability and availability of stainless steel to drive market
  • 7.3.2 TITANIUM ALLOYS
    • 7.3.2.1 Biocompatibility and ability to withstand high stress to propel adoption
  • 7.3.3 OTHER METALS & METAL ALLOYS
• 7.4 POLYMERS
  • 7.4.1 DESIGN FLEXIBILITY AND TUNABLE PROPERTIES OF POLYMERS TO PROPEL GROWTH
• 7.5 CERAMICS
  • 7.5.1 LOW FRICTIONAL PROPERTIES AND RESISTANCE AGAINST WEAR TO FUEL MARKET

8 ORTHOPEDIC IMPLANTS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & SURGICAL CENTERS
  • 8.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET
• 8.3 AMBULATORY & TRAUMA CARE CENTERS
  • 8.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH

9 ORTHOPEDIC IMPLANTS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American orthopedic implants market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Rising incidence of degenerative bone diseases to support market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to account for largest market share in Europe
  • 9.3.3 FRANCE
    • 9.3.3.1 Increasing obesity and significant adoption of orthopedic implants to support market growth
  • 9.3.4 UK
    • 9.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments
  • 9.3.5 ITALY
    • 9.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing preference for minimally invasive surgical procedures to drive market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rapidly growing geriatric population to propel market
  • 9.4.3 CHINA
    • 9.4.3.1 Expanding target patient population to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Favorable government initiatives to promote market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Rising R&D and funding to drive market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Strong presence of global players to drive market
  • 9.5.3 MEXICO
    • 9.5.3.1 Favorable investment scenario for medical device manufacturers to favor market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORTHOPEDIC IMPLANTS MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Type footprint
    • 10.5.5.4 Material footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES & APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ZIMMER BIOMET HOLDINGS, INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 STRYKER CORPORATION
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
      • 11.1.2.3.2 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 JOHNSON & JOHNSON MEDTECH
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches & approvals
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 SMITH+NEPHEW
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches & approvals
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Expansions
  • 11.1.5 B. BRAUN
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
  • 11.1.6 GLOBUS MEDICAL, INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches & approvals
      • 11.1.6.3.2 Deals
  • 11.1.7 ARTHREX, INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 ENOVIS
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Deals
      • 11.1.8.3.3 Expansions
  • 11.1.9 ACUMED LLC
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
      • 11.1.9.3.2 Deals
      • 11.1.9.3.3 Expansions
  • 11.1.10 ORTHOFIX MEDICAL INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches & approvals
      • 11.1.10.3.2 Deals
  • 11.1.11 MICROPORT SCIENTIFIC CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
  • 11.1.12 CONMED CORPORATION
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 MEDACTA INTERNATIONAL
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Product approvals
      • 11.1.13.3.2 Deals
      • 11.1.13.3.3 Expansions
  • 11.1.14 PARAGON 28, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches & approvals
      • 11.1.14.3.2 Deals
  • 11.1.15 MERIL LIFE SCIENCES PVT. LTD.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Expansions
• 11.2 OTHER PLAYERS
  • 11.2.1 FH ORTHO SAS
  • 11.2.2 SYMBIOS ORTHOPEDIE S.A.
  • 11.2.3 MADISON ORTHO
  • 11.2.4 GREEN SURGICALS PVT. LTD.
  • 11.2.5 SIORA SURGICALS PRIVATE LIMITED
  • 11.2.6 ORTHOPEDIATRICS CORP.
  • 11.2.7 RESTOR3D
  • 11.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
  • 11.2.9 TREACE MEDICAL CONCEPTS, INC.
  • 11.2.10 AK MEDICAL HOLDINGS LIMITED

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS